SOST and periodontitis: To determine the effect of IFX on osteocytic sclerostin expression in type 1 diabetes with periodontitis, we counted the number of sclerostin-positive osteocytes (Fig 4A) and measured sclerostin mRNA expression in alveolar bone of the distal area (Fig 4B).